A Study of AAV9 Gene Therapy in Participants With Canavan Disease (CANaspire Clinical Trial)

Clinical trial NCT04998396 · RECRUITING

Trial details

NCT number: NCT04998396
Sponsor: Aspa Therapeutics
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Canavan Disease

Start date: 2021-09-08
Primary completion: 2026-10-13
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.